244 related articles for article (PubMed ID: 16569533)
1. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design.
Ohman EM; Bhatt DL; Steg PG; Goto S; Hirsch AT; Liau CS; Mas JL; Richard AJ; Röther J; Wilson PW;
Am Heart J; 2006 Apr; 151(4):786.e1-10. PubMed ID: 16569533
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH Registry.
Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Steg PG; Cannon CP; Brennan DM; Bhatt DL;
Crit Pathw Cardiol; 2009 Jun; 8(2):91-7. PubMed ID: 19417637
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
Krempf M; Parhofer KG; Steg PG; Bhatt DL; Ohman EM; Röther J; Goto S; Pasquet B; Wilson PW;
Am J Cardiol; 2010 Mar; 105(5):667-71. PubMed ID: 20185014
[TBL] [Abstract][Full Text] [Related]
4. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry.
Uchiyama S; Goto S; Matsumoto M; Nagai R; Origasa H; Yamazaki T; Shigematsu H; Shimada K; Yamada N; Bhatt DL; Steg PG; Ikeda Y;
J Neurol Sci; 2009 Dec; 287(1-2):45-51. PubMed ID: 19815240
[TBL] [Abstract][Full Text] [Related]
6. One-year costs in patients with a history of or at risk for atherothrombosis in the United States.
Mahoney EM; Wang K; Cohen DJ; Hirsch AT; Alberts MJ; Eagle K; Mosse F; Jackson JD; Steg PG; Bhatt DL;
Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):38-45. PubMed ID: 20031786
[TBL] [Abstract][Full Text] [Related]
7. The economic implications of treating atherothrombotic disease in Australia, from the government perspective.
Ademi Z; Liew D; Hollingsworth B; Wolfe R; Steg GP; Bhatt DL; Reid CM;
Clin Ther; 2010 Jan; 32(1):119-32; discussion 106-7. PubMed ID: 20171418
[TBL] [Abstract][Full Text] [Related]
8. Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
Cannon CP; Rhee KE; Califf RM; Boden WE; Hirsch AT; Alberts MJ; Cable G; Shao M; Ohman EM; Steg PG; Eagle KA; Bhatt DL;
Am J Cardiol; 2010 Feb; 105(4):445-52. PubMed ID: 20152237
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
Baumgartner I; Hirsch AT; Abola MT; Cacoub PP; Poldermans D; Steg PG; Creager MA; Bhatt DL;
J Vasc Surg; 2008 Oct; 48(4):808-14. PubMed ID: 18639426
[TBL] [Abstract][Full Text] [Related]
10. A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Bhatt DL; Fox KA; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Flather MD; Haffner SM; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Booth J; Topol EJ;
Am Heart J; 2005 Sep; 150(3):401. PubMed ID: 16169314
[TBL] [Abstract][Full Text] [Related]
11. [The best of epidemiology and cardiovascular prevention in 2006].
Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
[TBL] [Abstract][Full Text] [Related]
12. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
[TBL] [Abstract][Full Text] [Related]
13. An annual, prospective, international study of outpatients with cardiovascular disease or risk factors: design and methods of the CardioMonitor registry.
Steinberg BA; Ballantyne CM; Bhatt DL; Montalescot G; Mehta S; O'Hagan P; Poole-Wilson PA; Cannon CP
Crit Pathw Cardiol; 2007 Jun; 6(2):72-5. PubMed ID: 17667869
[TBL] [Abstract][Full Text] [Related]
14. Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry.
Ducrocq G; Bhatt DL; Labreuche J; Corbalan R; Porath A; Gao R; Panchenko E; Liau CS; Ikeda Y; Goto S; Amarenco P; Steg PG
Eur J Prev Cardiol; 2014 Dec; 21(12):1509-16. PubMed ID: 23965467
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA).
Monreal M; Alvarez L; Vilaseca B; Coll R; Suárez C; Toril J; Sanclemente C;
Eur J Intern Med; 2008 May; 19(3):192-7. PubMed ID: 18395163
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.
Goto S; Bhatt DL; Röther J; Alberts M; Hill MD; Ikeda Y; Uchiyama S; D'Agostino R; Ohman EM; Liau CS; Hirsch AT; Mas JL; Wilson PW; Corbalán R; Aichner F; Steg PG;
Am Heart J; 2008 Nov; 156(5):855-63, 863.e2. PubMed ID: 19061698
[TBL] [Abstract][Full Text] [Related]
18. Demographics, socio-economic characteristics, and risk factor prevalence in patients with non-cardioembolic ischaemic stroke in low- and middle-income countries: the OPTIC registry.
Abboud H; Labreuche J; Arauz A; Bryer A; Lavados PG; Massaro A; Munoz Collazos M; Steg PG; Yamout BI; Vicaut E; Amarenco P;
Int J Stroke; 2013 Oct; 8 Suppl A100():4-13. PubMed ID: 22974118
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis in Israel.
Barski L; Porath A; Novack V; Jotkowitz A
Isr Med Assoc J; 2007 May; 9(5):376-9. PubMed ID: 17591377
[TBL] [Abstract][Full Text] [Related]
20. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
